Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease

Ageing Res Rev. 2022 Jun:78:101618. doi: 10.1016/j.arr.2022.101618. Epub 2022 Apr 5.

Abstract

Parkinson's disease (PD) is the second most common age-associated neurodegenerative disorder and is characterised by progressive loss of dopamine neurons in the substantia nigra. Peripheral immune cell infiltration and activation of microglia and astrocytes are observed in PD, a process called neuroinflammation. Neuroinflammation is a fundamental response to protect the brain but, when chronic, it triggers neuronal damage. In the last decade, central and peripheral inflammation were suggested to occur at the prodromal stage of PD, sustained throughout disease progression, and may play a significant role in the pathology. Understanding the pathological mechanisms of PD has been a high priority in research, primarily to find effective treatments once symptoms are present. Evidence indicates that early life exposure to neuroinflammation as a consequence of life events, environmental or behaviour factors such as exposure to infections, pollution or a high fat diet increase the risk of developing PD. Many studies show healthy habits and products that decrease neuroinflammation also reduce the risk of PD. Here, we aim to stimulate discussion about the role of neuroinflammation in PD onset and progression. We highlight that reducing neuroinflammation throughout the lifespan is critical for preventing idiopathic PD, and present epidemiological studies that detail risk and protective factors. It is possible that introducing lifestyle changes that reduce neuroinflammation at the time of PD diagnosis may slow symptom progression. Finally, we discuss compounds and therapeutics to treat the neuroinflammation associated with PD.

Keywords: Anti-inflammatory; Lifestyle; Microglia; Neuroinflammation; Parkinson’s disease; Prevention.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Disease Progression
  • Dopaminergic Neurons / pathology
  • Humans
  • Inflammation
  • Life Style
  • Microglia
  • Neuroinflammatory Diseases
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / prevention & control
  • Substantia Nigra / pathology